These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36962104)

  • 61. The TB vaccine development pathway - An innovative approach to accelerating global TB vaccine development.
    Roordink D; Williams A; Fritzell B; Laddy DJ; Gerdil E; Graffin AM; Tait D; van der Pol L; van den Brink I; Holleman M; Thole J; Voss G; Lempicki M; Thiry G
    Tuberculosis (Edinb); 2021 Jan; 126():102040. PubMed ID: 33310626
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Delivery strategies for malaria vaccination in areas with seasonal malaria transmission.
    Grant J; Diawara H; Traore S; Koita F; Myers J; Sagara I; Chandramohan D; Dicko A; Greenwood B; Webster J
    BMJ Glob Health; 2023 May; 8(5):. PubMed ID: 37147016
    [TBL] [Abstract][Full Text] [Related]  

  • 63. BCG vaccination strategies against tuberculosis: updates and perspectives.
    Qu M; Zhou X; Li H
    Hum Vaccin Immunother; 2021 Dec; 17(12):5284-5295. PubMed ID: 34856853
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.
    Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group
    Vaccine; 2015 Jun; 33(26):3047-55. PubMed ID: 25882170
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Healthcare worker perceived barriers and facilitators to implementing a tuberculosis preventive therapy program in rural South Africa: a content analysis using the consolidated framework for implementation research.
    van de Water BJ; Wilson M; le Roux K; Gaunt B; Gimbel S; Ware NC
    Implement Sci Commun; 2023 Aug; 4(1):107. PubMed ID: 37649057
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tuberculosis vaccines: Opportunities and challenges.
    Zhu B; Dockrell HM; Ottenhoff THM; Evans TG; Zhang Y
    Respirology; 2018 Apr; 23(4):359-368. PubMed ID: 29341430
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial.
    Idoko OT; Owolabi OA; Owiafe PK; Moris P; Odutola A; Bollaerts A; Ogundare E; Jongert E; Demoitié MA; Ofori-Anyinam O; Ota MO
    Tuberculosis (Edinb); 2014 Dec; 94(6):564-78. PubMed ID: 25305000
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Model-based impact evaluation of new tuberculosis vaccines in aging populations under different modeling scenarios: the case of China.
    Tovar M; Sanz J; Moreno Y
    Front Public Health; 2024; 12():1302688. PubMed ID: 38463158
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acceptability of decentralizing childhood tuberculosis diagnosis in low-income countries with high tuberculosis incidence: Experiences and perceptions from health care workers in Sub-Saharan Africa and South-East Asia.
    Joshi B; De Lima YV; Massom DM; Kaing S; Banga MF; Kamara ET; Sesay S; Borand L; Taguebue JV; Moh R; Khosa C; Breton G; Mwanga-Amumpaire J; Bonnet M; Wobudeya E; Marcy O; Orne-Gliemann J;
    PLOS Glob Public Health; 2023; 3(10):e0001525. PubMed ID: 37819919
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Patient and provider perception of appropriateness, acceptability, and feasibility of behavioral health home (BHH) core components based on program implementation in an urban, safety-net health system.
    Progovac AM; Tepper MC; Stephen Leff H; Cortés DE; Cohen Colts A; Ault-Brutus A; Hou SS; Lu F; Banbury S; Sunder D; Cook BL
    Implement Res Pract; 2021; 2():26334895211043791. PubMed ID: 37089996
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Acceptability, Adaptability, and Feasibility of a Novel Computer-Based Virtual Counselor-Delivered Alcohol Intervention: Focus Group and In-depth Interview Study Among Adults With HIV or Tuberculosis in Indian Clinical Settings.
    Suryavanshi N; Dhumal G; Cox SR; Sangle S; DeLuca A; Santre M; Gupta A; Chander G; Hutton H
    JMIR Form Res; 2022 May; 6(5):e35835. PubMed ID: 35622406
    [TBL] [Abstract][Full Text] [Related]  

  • 72. NATCON 2022 Panel discussion: "TB vaccination - Going Forward".
    Banurekha VV; Padmapriyadarsini C; Bhargava S; Sachdeva K
    Indian J Tuberc; 2023 Jul; 70(3):366-369. PubMed ID: 37562914
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A century of BCG: Impact on tuberculosis control and beyond.
    Ahmed A; Rakshit S; Adiga V; Dias M; Dwarkanath P; D'Souza G; Vyakarnam A
    Immunol Rev; 2021 May; 301(1):98-121. PubMed ID: 33955564
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tuberculosis: vaccines in the pipeline.
    Ly LH; McMurray DN
    Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV.
    Nathavitharana RR; Lederer P; Chaplin M; Bjerrum S; Steingart KR; Shah M
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014641. PubMed ID: 34416013
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts.
    Cox SR; Kadam A; Atre S; Gupte AN; Sohn H; Gupte N; Sawant T; Mhadeshwar V; Thompson R; Kendall E; Hoffmann C; Suryavanshi N; Kerrigan D; Tripathy S; Kakrani A; Barthwal MS; Mave V; Golub JE;
    Trials; 2022 Aug; 23(1):635. PubMed ID: 35932062
    [TBL] [Abstract][Full Text] [Related]  

  • 77. "I got tested at home, the help came to me": acceptability and feasibility of home-based TB testing of household contacts using portable molecular diagnostics in South Africa.
    Medina-Marino A; de Vos L; Bezuidenhout D; Denkinger CM; Schumacher SG; Shin SS; Stevens W; Theron G; van der Walt M; Daniels J
    Trop Med Int Health; 2021 Mar; 26(3):343-354. PubMed ID: 33289194
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa.
    Channing L; Sinanovic E
    Cost Eff Resour Alloc; 2014; 12():20. PubMed ID: 25242892
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.